Product description
Tesamorelin is a synthetic 44-amino acid analog of Growth Hormone-Releasing Hormone (GHRH) with a trans-3-hexenoic acid modification. In neuroendocrine literature, it is researched for its selective ability to stimulate the synthesis and release of endogenous growth hormone (GH) from pituitary somatotrophs without disrupting basal feedback loops.
Primary research focus
-
Pituitary Somatotroph Stimulation
Investigated for its selective interaction with GHRH receptors to elevate circulating IGF-1.
-
Visceral Adipose Tissue Metabolism
Evaluated in clinical and preclinical literature for targeted lipolysis of deep abdominal fat tissue.
-
Cognitive & Metabolic Signaling
Studied in relation to lipid profiles, glucose regulation, and neuronal integrity.

